|Articles|March 31, 2023
- Brukinsa® zanubrutinib 80mg capsules: Clinical Monograph
Brukinsa® zanubrutinib 80mg capsules: Clinical Monograph
Advertisement
Brukinsa® zanubrutinib 80mg capsules: Clinical Monograph
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Q&A: How Pharmacists Can Address Structural Barriers in Obesity Care
5






















